Alnylam Pharmaceuticals | ALNY - 员工总数

股票价格

321.18

每天变化

-6.07 -1.85%

每月一次

-0.37%

每年

41.94%

Q2 预测

309.25

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 41.47B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	员工	更改		日
Acadia Pharmaceuticals	653		56	2024-12
Agios Pharmaceuticals	486		103	2024-12
Alnylam Pharmaceuticals	2.23K		130	2024-12
Amgen	28K		1.3K	2024-12
Arrowhead Research	711		102	2025-12
BioCryst Pharmaceuticals	536		5	2023-12
BioMarin Pharmaceutical	3.04K		361	2024-12
Incyte	2.62K		93	2024-12
Ionis Pharmaceuticals	1.07K		142	2024-12
Moderna	5.8K		200	2024-12
Neurocrine Biosciences	1.8K		400	2024-12
Novartis	101.7K		2.62K	2022-12
PTC Therapeutics	939		49	2024-12
Regeneron Pharmaceuticals	13.45K		1.6K	2023-12
Sangamo BioSciences	405		73	2023-12
Sanofi	EUR 91.57K		3.87K	2022-12
Sarepta Therapeutics	1.37K		58	2024-12
Takeda	47.46K		1.83K	2025-12
Tectonic Therapeutic	45		1	2023-12
Ultragenyx Pharmaceutical	1.29K		18	2024-12
Vertex Pharmaceuticals	6.1K		700	2024-12
Xencor	250		30	2024-12